SURE(SHOT): YOUR MEDICAL SUPPLY CHAIN MONITOR, FOR YOUR PUBLIC HEALTH. Collective end-user verification+packaging for vaccine confidence.
Generating information to verify safe vaccine usage and supply chain, by collective end-user self-reporting, for end-user confidence.
Describe what you intend to do and how you'll do it in one sentence (required 250 Characters)
SureShot is an algorithmic verification tool for vaccine credibility furnished w/end-user reported data via low-cost encrypted labels that connect users with individual syringe info, we the public develop our own data+trust-factors around medication.
Explain the idea (less than 2,000 characters)
Vaccines are crucial to public health. Yet, there are anti-vaccination movement and lasting misconception about vaccines globally (i.e., WHO reported a 30 billion market of counterfeit drugs in developing countries, 2017). Even in developed countries, there is critical medical info asymmetry among stakeholders. Systemically, the current vaccine supply chain lacks a holistic approach to detect counterfeit, contaminated, expired, and ineffective vaccines.
Currently, trust is most undermined in public health services in developing countries where public health literacy and the development of a medical supply chain are limited. In 2017, 80% of vaccines are delivered to these countries. Our product targets vaccine consumers, to construct trust and help gov’t bodies and manufacturers in monitoring the use of vaccines in developing countries.
Our solution includes two parts:
(system level) An integrated label on the pre-filled syringes (PFS) to ensure safety along the supply chain
(personal level) A mobile app for consumers to self-check & self-report the vaccine safety before & after the injection to build the public trust of vaccination in the community
The integrated syringe label contains three layers:
Algorithmic verification layer leveraging machine learning to detect the geo-location, related entries, and the medical provider information.
Thermochromic material layer helps determine if an individual product has a failure in cold-chain.
Adhesive layer to make the label function as bandage after the injection to integrate the label into the natural injection process
The SureShot mobile app allows consumers to scan before injection to acquire information tracked on an individual syringe, self-check the integrity, and share/self-report the experience to the community/gov’t to build vaccine confidence at large scale. If issues are detected, the govt may take immediate actions by utilizing the self-reported data (i.e., flag affected medicines of the same batch)
Which part(s) of the world does this idea target?
Geographic Focus (less than 250 Characters)
Tools for end-user confidence in vaccines is globally applicable, but especially important for countries currently transferring from donated vaccines to their own supply chain (e.g. Indonesia, Ghana, China).
Who are your end users and how well do you know them? (750 characters)
End users are individuals making the decision to have a vaccine administered to them or their child/family members, with access to a smartphone.
"Individual choice" is the asset of these end users -vaccine coverage depends on individuals and public perception, as much as medical practitioner (e.g. the 1970 Japanese Pertussis "loss of confidence event", 40% loss in coverage).
However, individuals are not provided the same information as medical professionals or suppliers, thus it is hard for individuals to source credible info and make educated choices about the credibility of a vaccine.
Self-reporting is a collective asset that can enable to help to 3rd party police the validity and good practice in supply chain of vaccination.
How is the idea unique? (750 Characters)
This idea transfers existing strategies+well-understood tools from areas of "consumer confidence"/"banking confidence", and applies them to medical goods. I.e. the machine-learning algorithms similar to those used to detect credit card fraud can be used to query a "vaccine administration event" based on reportable data (e.g, location, date, lot-number, etc. in comparison to other data points) to develop an idea of a credible vaccine (e.g., one that is not counterfeit, expired, related to batches with cold chain failure or recall).
Giving users an interface to their medical devices/drugs is an emergent and empowering trend. This approach generates data from users, and encourages incr. data sharing (transparency) btwn supply chain actors.
Idea Proposal Stage (Select 1)
Blueprint: We are exploring the idea and gathering the inspiration and information we need to test it with real users.
How many months are required for the project idea? (140 characters)
It will take 1-2 years to implement phase 1: to build an app and prototype label, and find company/gov't partners to adopt for testing.
Organization Name (less than 140 characters)
Type of Submitter
We are not yet a registered organization but looking for collaborative partners
University Students, Female co-led project team
Organization Location (less than 140 Characters)
Cambridge, MA, USA
What is the current scale of your organization’s work?
Community (working within one or a few local communities within a region)
Tell us more about your organization/company (1-2 sentences)
We are MIT/U. of Hong Kong graduate students, from Bio-engineering, Business, Urban Planning, and Design disciplines. We can source resources from within our academic community and network.
Who will work alongside your organization in the project idea? (750 characters)
(1) Large Vaccine manufacturers that export vaccines to other countries, as they take responsibility in the transportation and QC of vaccines, and reclaim market values from counterfeiters.. I.e. GlaxoKlein, which have already shown interest in vaccine label innovation.
(2)Local vaccine manufacturers, as developing countries have an interest in competitive vaccine manufacturing domestically.
(3) Governments, interested in effectively managing and respond to crisis by tracing vaccination to a specific batch of immunized population. E.g, via local hospitals in Southeast Asia encourage the adoption of the vaccine supply chain verification.
(4) General Public, to access information + participate in a better communicated collective reality
How many people are on your team?
Tell us more about you and your team
+Rachel Smith, MIT Media Lab (c.PhD), B.S. Biomedical Engineering. Experience in biomedical translation to industry. Founded PhageFlag to develop a low-resource bacterial diagnostics, and served as president of UVA Engineering Students w/out Borders.
+Yujie Wang, MIT School of Architecture + Planning. He specializes in AI-IoT product design & dev and HCI, awarded/exhibited internationally. He co-founded Tagface, a Toronto startup to reduce food waste in the food supply chain via adaptive pricing.
+Xiaoyue Gong, MIT Operations Research Center, c.PhD. She researches supply chain mgmt using algorithms, machine learning and optimization. Past experience in healthcare/environment-related social venture.
+Adolphus Lau, U.of Hong Kong, Urban Planning and Intn’l Dev. He develops community empowerment and economic reconstruction projects in Greater China/ASEAN at a Hong Kong-based thinktank. Co-founded Tagface.
As a team, we have a common passion in public health and community partnerships.